Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

businessinsider.com - Madeline Berg - The GLP-1 gold rush is creating winners far beyond pharma
The GLP-1 gold rush is creating winners far beyond pharma
Business Insider

Every month, sales executive Kelly Freeman spends about $112 on Ozempic, which he started taking in 2024 for diabetes. The drug is one line item in a long list of GLP-related costs. There are supplements, an Apple watch, a life coach, a functional…

cnbc.com - Elsa Ohlen - Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
CNBC

Once the go-to location for global drugmakers, Europe is losing market share to aggressive U.S. trade policies and China's growth as a biotech hub. Europe's share of global R&D has been cut in half over the past 35 years, with more companies…

news-medical.net - Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar
Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar
News-Medical

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science. To explore these advancements, Insilico Medicine…

scroll.in - Chinmay Tumbe  - 'Made in India': A fine exposition of the personal and professional in creating pharma brand Lupin
'Made in India': A fine exposition of the personal and professional in creating pharma brand Lupin
Scroll.in

Is there any major Indian industry without the dominance of the Tatas, Birlas, Ambanis, and other large legacy business houses? Think of IT and automobiles, and you run into TCS and Tata Motors. If it is finance, you have the Bajajs. Take any of…

marketbeat.com - OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of 'Hold' by Brokerages
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of 'Hold' by Brokerages
MarketBeat

Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) have been given an average rating of 'Hold' by the five analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one…

swissinfo.ch - swissinfo.ch - Dressing room fire forces Basel to postpone football match
Dressing room fire forces Basel to postpone football match
www.swissinfo.ch

Swiss entrepreneurs are staying put in Dubai Read more: Swiss entrepreneurs are staying put in Dubai Public support for the army, Jamie Dimon's warnings, and the Artemis II Moon mission Read more: Public support for the army, Jamie Dimon's…

swissinfo.ch - swissinfo.ch - World skiing championship for toddlers held in Switzerland
World skiing championship for toddlers held in Switzerland
www.swissinfo.ch

The programme for these young skiers includes training sessions, followed by three age-appropriate competitions in giant slalom, combined slalom and parallel slalom. A ranking will be drawn up after each race, followed by an overall ranking to…

thehindu.com - The Hindu Bureau - Orbicular's Ozempic generic gets U.S. FDA tentative nod
Orbicular's Ozempic generic gets U.S. FDA tentative nod
The Hindu

A generic version of Ozempic (semaglutide injection) developed by Hyderabad-based Orbicular Pharmaceutical Technologies in partnership with Florida-headquartered Apotex Corp. has received tentative approval from the U.S. Food and Drug…

thehindu.com - The Hindu Bureau - Power is not permanent, KTR warns Revanth
Power is not permanent, KTR warns Revanth
The Hindu

Bharat Rashtra Samithi (BRS) working president K.T. Rama Rao has observed that power is not permanent in a democracy, and the day of people teaching a fitting lesson to Chief Minister A. Revanth Reddy is not far away for not keeping the promises…

thehindu.com - Pti - Goyal holds talks with Saudi Trade Minister on strengthening supply chains
Goyal holds talks with Saudi Trade Minister on strengthening supply chains
The Hindu

Commerce and Industry Minister Piyush Goyal on Saturday (April 11, 2026) held discussions with Saudi Arabia's Trade Minister Majid bin Abdullah Al-Qassabi on ways to strengthen supply chains disrupted due to the West Asia crisis, after holding…

marketbeat.com - Growth Stocks To Keep An Eye On - April 11th
Growth Stocks To Keep An Eye On - April 11th
MarketBeat

3 Under-the-Radar AI Infrastructure Stocks Powering the Next Buildout Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of…

science20.com - UC Davis Gives Government Bans Credit For Ending The Vaping Fad
UC Davis Gives Government Bans Credit For Ending The Vaping Fad
Science 2.0

During the Obama administration, the credibility of the US Centers for Disease Control went into serious decline. Though it only became evident to most how incompetent career government bureaucrats were when COVID-19 hit - they denied it was a…

hollywoodreporter.com - Julian Sancton - Patrick Radden Keefe Is Hollywood's New Favorite Author
Patrick Radden Keefe Is Hollywood's New Favorite Author
The Hollywood Reporter

Screenwriters secretly envy book authors for their intellectual prestige and creative control, and authors secretly dream of working in Hollywood. Few writers straddle both worlds with the aplomb of Patrick Radden Keefe. To give you a sense: He…

thehindubusinessline.com - Caplin Point: Consolidating before the next leg of growth
Caplin Point: Consolidating before the next leg of growth
BusinessLine

Caplin Point has entered a consolidation phase, stock-price wise and business-momentum wise. The stock has returned 80-90 per cent from our first accumulate call in July 2022 to April 2024 and again delivered similar returns from April 2024 to…

marketbeat.com - Bristol Myers Squibb (NYSE:BMY) Rating Lowered to Buy at Wall Street Zen
Bristol Myers Squibb (NYSE:BMY) Rating Lowered to Buy at Wall Street Zen
MarketBeat

Bristol Myers Squibb (NYSE:BMY - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a 'strong-buy' rating to a 'buy' rating in a research report issued to clients and investors on Saturday. 2 Buffett Stocks to Load Up…

Receive a Daily briefing on Pharma Industry News

Get Started